Loading...
Anti-VEGFR2 Recombinant Antibody Products
Loading...Anti-VEGFR2 Products
-
- Species Reactivity: Human
- Type: Human IgG
- Application: WB, IF, FuncS
- Rabbit Anti-VEGFR2 Recombinant Antibody (VS-0723-WK219) (VS-0723-WK219)
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: ELISA, FC
- Human Anti-VEGFR2 Recombinant Antibody (TAB-0021CL) (TAB-0021CL)
-
- Derivation: Human
- Species Reactivity: Does not bind to mouse VEGFR2
- Type: Human IgG1
- Application: ELISA, Block
- Human Anti-VEGFR2 Recombinant Antibody; scFv Fragment (TAB-0021CL-S(P)) (TAB-0021CL-S(P))
-
- Derivation: Human
- Species Reactivity: Does not bind to mouse VEGFR2
- Type: Human scFv
- Application: ELISA, Block
- Human Anti-VEGFR2 Recombinant Antibody; Fab Fragment (TAB-0021CL-F(E)) (TAB-0021CL-F(E))
-
- Derivation: Human
- Species Reactivity: Does not bind to mouse VEGFR2
- Type: Human Fab
- Application: ELISA, Block
-
- Species Reactivity: Human
- Type: Human antibody
- Application: ELISA
-
- Species Reactivity: Human
- Type: Human antibody
- Application: ELISA
-
- Species Reactivity: Human
- Type: Human antibody
- Application: Block, ELISA, WB
-
- Species Reactivity: Human
- Type: Human antibody
- Application: Block, ELISA, WB
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, WB
-
- Derivation: Humanized
- Species Reactivity: Human, Mouse, Monkey
- Type: Human IgG1, κ
- Application: ELISA, WB
- Mouse Anti-VEGFR2 Recombinant Antibody (HPAB-2710LY) (HPAB-2710LY)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody (HPAB-2711LY) (HPAB-2711LY)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody (HPAB-2712LY) (HPAB-2712LY)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody (HPAB-2713LY) (HPAB-2713LY)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody (clone CBL054) (HPAB-2714LY)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody (clone CBL055) (HPAB-2715LY)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody (HPAB-2716LY) (HPAB-2716LY)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, Inhib
-
- Derivation: Humanized
- Species Reactivity: Human, Mouse, Monkey
- Type: Human scFv
- Application: ELISA, WB, Block
- Human Anti-VEGFR2 Recombinant Antibody (HPAB-0041LY) (HPAB-0041LY)
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human IgG1
- Application: WB, IF, Block
- Camel Anti-VEGFR2 Recombinant Antibody (clone V21H1) (FAMAB-0366WJ)
-
- Species Reactivity: Human
- Type: Camelid VHH
- Application: ELISA, WB, FC
- Camel Anti-VEGFR2 Recombinant Antibody (clone V21H4) (FAMAB-0367WJ)
-
- Species Reactivity: Human
- Type: Camelid VHH
- Application: ELISA, WB, FC
-
- Derivation: Humanized
- Species Reactivity: Human, Mouse, Monkey
- Type: Humanized Fab
- Application: ELISA, WB, Block
- Human Anti-VEGFR2 Recombinant Antibody; scFv Fragment (HPAB-0041LY-S(P)) (HPAB-0041LY-S(P))
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human scfv
- Application: WB
- Mouse Anti-VEGFR2 Recombinant Antibody (clone CBL054); scfv Fragment (HPAB-2714LY-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scfv
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody (clone CBL055); scfv Fragment (HPAB-2715LY-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scfv
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody; scFv Fragment (HPAB-2716LY-S(P)) (HPAB-2716LY-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scfv
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody (clone CBL055); Fab Fragment (HPAB-2715LY-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody; Fab Fragment (HPAB-2716LY-F(E)) (HPAB-2716LY-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, Inhib
-
- Species Reactivity: Human, Mouse, Monkey
- Type: Rabbit Fab
- Application: ELISA, WB, Block
- Human Anti-VEGFR2 Recombinant Antibody; Fab Fragment (HPAB-0041LY-F(E)) (HPAB-0041LY-F(E))
-
- Derivation: Human
- Species Reactivity: Human
- Type: Human Fab
- Application: WB
- Mouse Anti-VEGFR2 Recombinant Antibody; Fab Fragment (HPAB-2710LY-F(E)) (HPAB-2710LY-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody; Fab Fragment (HPAB-2711LY-F(E)) (HPAB-2711LY-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody; Fab Fragment (HPAB-2712LY-F(E)) (HPAB-2712LY-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody; Fab Fragment (HPAB-2713LY-F(E)) (HPAB-2713LY-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody (clone CBL054); Fab Fragment (HPAB-2714LY-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody; scFv Fragment (HPAB-2710LY-S(P)) (HPAB-2710LY-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scfv
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody; scFv Fragment (HPAB-2711LY-S(P)) (HPAB-2711LY-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scfv
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody; scFv Fragment (HPAB-2712LY-S(P)) (HPAB-2712LY-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scfv
- Application: ELISA, Inhib
- Mouse Anti-VEGFR2 Recombinant Antibody; scFv Fragment (HPAB-2713LY-S(P)) (HPAB-2713LY-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scfv
- Application: ELISA, Inhib
-
- Species Reactivity: Human, Mouse, Monkey
- Type: Rabbit IgG
- Application: ELISA, WB, Block
-
- Species Reactivity: Human, Mouse, Monkey
- Type: Rabbit scFv
- Application: ELISA, WB, Block
-
- Species Reactivity: Human
- Type: Human Fab
- Application: WB, IF, FuncS
-
- Species Reactivity: Human
- Type: Human scFv
- Application: WB, IF, FuncS
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: WB, IF, Block
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs stands as a global leader in advanced antibody discovery and engineering, proudly offering a superior range of anti-VEGFR2 recombinant antibody products. Meticulously designed for researchers and pharmaceutical developers worldwide, our antibodies deliver unparalleled specificity and exceptional reliability. This empowers groundbreaking studies in angiogenesis-related diseases, from cancer to ocular disorders, and accelerates the crucial path towards novel therapeutic development.
VEGFR2: A Pivotal Target for Anti-Angiogenic Therapy
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2), also known as KDR or Flk-1, is the primary receptor mediating VEGF-A's potent pro-angiogenic signals. It is critically involved in physiological blood vessel formation, essential for embryonic development, wound healing, and tissue repair. However, its dysregulated activity profoundly drives pathological angiogenesis, notably fueling tumor growth, nutrient supply, and metastatic spread in various cancers. Moreover, VEGFR2 contributes to conditions like age-related macular degeneration. Given this pivotal role, VEGFR2 is a highly significant target for developing effective anti-cancer therapies and other treatments for angiogenesis-driven diseases.
Alternative Names
KDR; kinase insert domain receptor; FLK1; CD309; VEGFR; VEGFR2; vascular endothelial growth factor receptor 2; soluble VEGFR2; fetal liver kinase 1; fetal liver kinase-1; protein-tyrosine kinase receptor Flk-1; tyrosine kinase growth factor receptor; kinase insert domain receptor (a type III receptor tyrosine kinase).
Background
Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas.
Anti-VEGFR2 rAb Products
Our anti-VEGFR2 recombinant antibody products stand out due to their exceptional purity, high affinity, and lot-to-lot consistency. Produced using advanced recombinant technology, these antibodies offer superior specificity for VEGFR2, minimizing off-target effects and ensuring reliable results in diverse research applications, from basic science to preclinical drug development.
| Cat. No. | Product Name | Target Species | Host Species | Applications |
| PABL-743 | Human Anti-VEGFR2 Recombinant Antibody (clone 1121B) | Human | Human IgG | WB, IF, FuncS |
| HPAB-2712LY | Mouse Anti-VEGFR2 Recombinant Antibody (HPAB-2712LY) | Human | Mouse IgG | ELISA, Inhib |
| HPAB-2714LY | Mouse Anti-VEGFR2 Recombinant Antibody (clone CBL054) | Human | Mouse IgG | ELISA, Inhib |
| HPAB-0041LY | Human Anti-VEGFR2 Recombinant Antibody (HPAB-0041LY) | Human | Human IgG1 | WB, IF, Block |
| FAMAB-0367WJ | Camel Anti-VEGFR2 Recombinant Antibody (clone V21H4) | Human | Camelid VHH | ELISA, WB, FC |
Table 1. Featured anti-VEGFR2 recombinant antibody products at Creative Biolabs.
Creative Quality Control
At Creative Biolabs, quality is our cornerstone. Our anti-VEGFR2 recombinant antibodies undergo rigorous, multi-stage quality control, including precise affinity measurements, specific binding validation against VEGFR2, and functional assays to confirm their biological activity. This meticulous process guarantees superior performance and reproducibility, providing researchers with confidence in their experimental outcomes.
Fig.1 SDS-PAGE analysis of anti-VEGFR2 antibody
(Cat# PABL-743, Creative Biolabs).
Customer Reviews
Human Anti-VEGFR2 Recombinant Antibody (clone 1121B) (PABL-743)
Human Anti-VEGFR2 Recombinant Antibody (clone 1121B) (PABL-743)
Mouse Anti-VEGFR2 Recombinant Antibody (HPAB-2713LY) (HPAB-2713LY)
rAb Production
Our anti-VEGFR2 recombinant antibodies are manufactured in state-of-the-art facilities using a proprietary mammalian expression system. This stringent production process ensures high yield, exceptional purity, and batch-to-batch consistency, delivering a reliable supply of premium-grade antibodies for your research demands.
Featured Anti-VEGFR2 Recombinant Antibody Production Platforms
Fig.2 Milligram-scale anti-VEGFR2 recombinant antibody production.
Fig.3 Gram-scale anti-VEGFR2 recombinant antibody production.
rAb Modalities
Creative Biolabs offers anti-VEGFR2 recombinant antibodies in multiple modalities, including monoclonal, polyclonal, and various engineered formats, providing versatile tools for a wide array of research and therapeutic development applications.
Fig.4 Full-length anti-VEGFR2 recombinant antibody production and modalities.
VEGFR2-Targeted Drug Information
| Company | Research phase | Classification | Condition |
| GeneScience Pharmaceuticals (Originator) | Phase III |
Cancer Immunotherapy Chimeric Monoclonal Antibodies |
Cancer, gastroesophageal junction Cancer, gastrointestinal Cancer, lung (non-small cell) (NSCLC) Cancer, lung (non-small cell) (NSCLC), metastatic Cancer, solid tumor |
|
3SBio PharmAbcine (Originator) |
Phase II |
Cancer Immunotherapy Human Monoclonal Antibodies |
Cancer Cancer, solid tumor Glioblastoma multiforme Triple negative breast cancer |
|
Merck KGaA Scripps Research (Originator) VAXIMM |
Phase I/II |
Cancer Immunotherapy Cancer Vaccines Recombinant Vector Vaccines |
Astrocytoma Cancer Cancer, colorectal Cancer, colorectal, metastatic Cancer, pancreas Glioblastoma Glioma |
|
National Cancer Institute (Originator) National Cancer Institute (NCI) (National Cancer Institute) |
Phase I/II |
Cancer Immunotherapy Chimeric Antigen Receptor-Modified T Cells (CAR T Cells) |
Cancer, metastatic |
| Pfizer (Originator) | Discontinued |
Cancer Immunotherapy Humanized Monoclonal Antibodies |
Cancer, solid tumor |
| Uppsala Universitet (UU) (Originator) | Preclinical |
Affibodies Nuclear Imaging Agents Polypeptides, from 41 AA Radiopharmaceuticals Recombinant proteins |
Glioma |
| National Health Research Institutes (Originator) | Preclinical |
Fc Fusion Proteins Polypeptides, from 41 AA Vascular Endothelial Growth Factors (VEGF) |
Cancer Melanoma |
|
Istituto Dermopatico Dell'Immacolata (Originator) Universita degli Studi Roma Tor Vergata (Originator) |
Preclinical |
Cancer Immunotherapy Murine Monoclonal Antibodies |
Cancer |
| First Affiliated Hospital Anhui Med Univ (Originator) | Preclinical | Short Hairpin RNA (shRNA) | Cancer, liver (hepatocellular carcinoma) |
|
Beth Israel Deaconess Medical Center (Originator) University of Massachusetts (Originator) |
Preclinical |
Double-stranded oligoribonucleotide (RNA) Small Interfering RNA (SiRNAs) |
Pre-eclampsia |
| University of Colorado (Originator) | Preclinical | Monoclonal Antibodies | Dysplasia, bronchopulmonary |
| Lilly (Originator) | Preclinical |
Bispecific Antibodies Cancer Immunotherapy Monoclonal Antibodies Single-Chain V-Domain Antibody Fragment (scFv) |
Cancer |
(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)
Table 2. Public drug targeting VEGFR2.
Boost your study with the state-of-the-art anti-VEGFR2 recombinant antibody products from Creative Biolabs. We invite you to explore the full potential of these highly validated reagents, designed to provide the precision and reliability your critical experiments demand. To learn more about our comprehensive offerings, discuss specific product specifications, or explore custom antibody development services tailored to your unique project needs, please do not hesitate to contact our expert team. We are dedicated to supporting your scientific breakthroughs and accelerating your path to discovery.


